MEDI 151-Mutual prodrugs of all-trans retinoic acid and histone deacetylase inhibitors: Potent anticancer agents

被引：0
|
作者：
Samori, Cristian [1 ]
Battaglia, Arturo [1 ]
Guerrini, Andrea [1 ]
Varchi, Greta [1 ]
Beretta, Giovanni Luca [2 ]
Zunino, Franco [2 ]
Fontana, Gabriele [3 ]
Bombardelli, Ezio [3 ]
机构：
[1] CNR, ISOF, I-40129 Bologna, Italy
[2] Ist Nazl Tumori, I-20133 Milan, Italy
[3] Indena SpA, I-20139 Milan, Italy
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 233卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
158-MEDI
引用
收藏
页码：877 / 877
页数：1
相关论文
共 50 条
  • [1] Mutual prodrugs of all-trans retinoic acid and histone deacetylase inhibitors: Potent anticancer agents
    Gediya, Lalji K.
    Khandelwal, Aakanksha
    Mehta, Jhalak
    Purushottamachar, Puranik
    Njar, Vincent C. O.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 761 - 761
  • [2] Enhanced anticancer activity of glutamate prodrugs of all-trans retinoic acid
    Cui, Chunying
    Zhang, Yunwei
    Wang, Lili
    Liu, Hu
    Cui, Guohui
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 (10) : 1353 - 1358
  • [3] Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells
    Katrin Noack
    Nisintha Mahendrarajah
    Dorle Hennig
    Luisa Schmidt
    Florian Grebien
    Dagmar Hildebrand
    Markus Christmann
    Bernd Kaina
    Andreas Sellmer
    Siavosh Mahboobi
    Katharina Kubatzky
    Thorsten Heinzel
    Oliver H. Krämer
    [J]. Archives of Toxicology, 2017, 91 : 2191 - 2208
  • [4] Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells
    Noack, Katrin
    Mahendrarajah, Nisintha
    Hennig, Dorle
    Schmidt, Luisa
    Grebien, Florian
    Hildebrand, Dagmar
    Christmann, Markus
    Kaina, Bernd
    Sellmer, Andreas
    Mahboobi, Siavosh
    Kubatzky, Katharina
    Heinzel, Thorsten
    Kraemer, Oliver H.
    [J]. ARCHIVES OF TOXICOLOGY, 2017, 91 (05) : 2191 - 2208
  • [5] Design, synthesis, and evaluation of novel mutual prodrugs (Hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitro
    Gediya, Laiji K.
    Khandelwal, Aakanksha
    Patel, Jyoti
    Belosay, Aashvini
    Sabnis, Gauri
    Mehta, Jhalak
    Purushottamachar, Puranik
    Njar, Vincent C. O.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3895 - 3904
  • [6] GENETIC BASIS OF CARDIAC DYSFUNCTION: PROTECTIVE ROLE OF ALL-TRANS RETINOIC ACID AND HISTONE DEACETYLASE INHIBITOR
    Pandey, K. N.
    Subramanian, U.
    Kumar, P.
    Mani, I.
    Kessler, I.
    Raghavaraju, R.
    [J]. CARDIOLOGY, 2016, 134 : 35 - 35
  • [7] Effect of the histone deacetylase inhibitor valproic acid in combination with all-trans retinoic acid on normal and malignant hematopoiesis.
    Guel, H
    Wassmann, B
    Romanski, A
    Hoelzer, D
    Ruthardt, M
    Ottmann, OG
    Bug, G
    [J]. BLOOD, 2003, 102 (11) : 626A - 627A
  • [8] Pharmacophore modeling investigation of all-trans retinoic acid inhibitors.
    Clement, OO
    Njar, VCO
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U284 - U284
  • [9] The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination moth all-trans retinoic acid in patients with acute myeloid leukemia
    Kuendgen, A
    Schmid, M
    Schlenk, R
    Knipp, S
    Hildebrandt, B
    Steidl, C
    Germing, U
    Haas, R
    Dohner, H
    Gattermann, N
    [J]. CANCER, 2006, 106 (01) : 112 - 119
  • [10] The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid
    Coffey, DC
    Kutko, MC
    Glick, RD
    Butler, LM
    Heller, G
    Rifkind, RA
    Marks, PA
    Richon, VM
    La Quaglia, MP
    [J]. CANCER RESEARCH, 2001, 61 (09) : 3591 - 3594
12345